Study Evaluating SCA-136 Tolerability With Dose Titration and Food

Stopped early · Phase 1

Conditions studied: Healthy

In brief

To evaluate whether the tolerability of SCA-136 is improved by dosing with food or by increasing dose amounts in a step-wise fashion.

Key facts

Study ID

NCT00420706

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

120

Starts

2006-12-01

Expected to finish

2006-12-01

Last updated by the study team

2007-12-10

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy men or women, aged 18 to 50 years

You may not qualify if…

• Abnormal vital signs, ECG, or lab results

Where it is running

• Study site — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.